Inhibitory effects of interferon-gamma plasmid DNA on DMBA-TPA induced mouse skin carcinogenesis

J-H Ko1, B-G Jung, Y-S Park

  • 1Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Chonnam National University, Gwangju, Republic of Korea.

Cancer Gene Therapy
|July 30, 2011
PubMed

Insights

Hydrodynamics-based gene therapy effectively uses interferon-gamma (IFN-γ) DNA to treat skin cancer in mice. This method reduced tumors and suppressed cancer cell growth without causing liver damage.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Interferon-gamma (IFN-γ) possesses tumor-suppressive properties.
  • IFN-γ gene therapy is a potential strategy for treating skin cancer.
  • Hydrodynamics-based gene delivery offers a method for in vivo gene transfection.

Purpose of the Study:

  • To evaluate the efficacy of hydrodynamics-based interferon-gamma (IFN-γ) gene transfection for skin cancer treatment.
  • To assess the safety and therapeutic effects of this gene therapy approach in a mouse model.

Main Methods:

  • Induced skin carcinogenesis in mice using 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
  • Administered plasmid DNA encoding IFN-γ into the tail vein via hydrodynamics-based transfection.
  • Monitored serum IFN-γ levels, liver toxicity, papilloma development, epidermal cell proliferation, and apoptosis.

Main Results:

  • Substantially elevated serum IFN-γ levels were achieved without observable liver toxicity.
  • Mice treated with IFN-γ plasmid DNA showed a significant reduction in papilloma numbers.
  • Suppressed epidermal cell proliferation and induced caspase-3-mediated apoptosis were observed in the treated group.

Conclusions:

  • Hydrodynamics-based transfection of IFN-γ plasmid DNA is a safe and effective method for skin cancer gene therapy.
  • This approach demonstrates potential for in vivo tumor suppression and treatment of skin malignancies.

Related Concept Videos